Bloomberg Intelligence cover image

Metsera Tumbles After Novo Pulls Out of Bidding War With Pfizer

Bloomberg Intelligence

00:00

MetSera takeover drama and drug data clarity

Paul asks about MetSera; Sam explains MetSera's weight-loss asset, safety profile, once-monthly dosing and the FTC's regulatory concerns that ended Novo's bid.

Play episode from 01:56
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app